Wojtun S, Gil J, Gietka W, Gil M
Digestive Endoscopy Unit, Central Clinical Hospital, Armed Forces Medical Academy, Warsaw, Poland.
Endoscopy. 1997 May;29(4):258-65. doi: 10.1055/s-2007-1004186.
Endoscopic sphincterotomy (EST) is the method of choice for the treatment of choledocholithiasis. The aim of the present study was to assess the impact of various prognostic factors on the short-term and long-term results of EST.
Data from 483 EST procedures carried out due to choledocholithiasis without concomitant neoplasms or hepatic cirrhosis, and without subsequent bile duct surgery, were analyzed prospectively. The 324 patients (67%) who agreed to take part in the follow-up examinations and fulfilled the inclusion criteria for the study were divided into four groups, depending on the presence of the gallbladder or cholecystolithiasis prior to EST and on the time of diagnosis, and were prospectively followed up by physical examination laboratory tests, abdominal ultrasound, and endoscopic retrograde cholangiography examinations to evaluate the short-term and long-term outcomes.
EST was successful in 95.7% of cases. Early complications were noted in 6.8% of cases. No early complications were seen in the group after cholecystectomy with a T-tube present, whereas this rate was highest in the group with concurrent choledocholithiasis and cholecystolithiasis (six of 48, 12.5%). Recurrent choledocholithiasis was observed in 5.6% of the cases overall. This rate was at its lowest in patients with choledocholithiasis alone, and was highest in the group with concurrent choledocholithiasis and cholecystolithiasis. Among the latter patients, the highest rates of papillary stenosis, chronic pancreatitis, and cholangitis were also observed, the latter complication being noted only in cases of recurrent common bile duct stones.
EST is a relatively safe and effective procedure in the treatment of choledocholithiasis. The best prognostic factor is the presence of choledocholithiasis alone. Concurrent choledocholithiasis and cholecystolithiasis carry a more adverse prognosis, and in these cases cholecystectomy should be considered after EST.
内镜括约肌切开术(EST)是治疗胆总管结石的首选方法。本研究旨在评估各种预后因素对EST短期和长期结果的影响。
对483例因胆总管结石行EST手术的数据进行前瞻性分析,这些患者无合并肿瘤或肝硬化,且术后未行胆管手术。324例(67%)同意参加随访检查并符合研究纳入标准的患者,根据EST术前是否存在胆囊或胆囊结石以及诊断时间分为四组,并通过体格检查、实验室检查、腹部超声和内镜逆行胆管造影检查进行前瞻性随访,以评估短期和长期结果。
EST成功率为95.7%。6.8%的病例出现早期并发症。放置T管的胆囊切除术后组未出现早期并发症,而胆总管结石合并胆囊结石组的这一发生率最高(48例中有6例,12.5%)。总体5.6%的病例观察到复发性胆总管结石。该发生率在单纯胆总管结石患者中最低,在胆总管结石合并胆囊结石组中最高。在后者中,乳头狭窄、慢性胰腺炎和胆管炎的发生率也最高,胆管炎并发症仅在复发性胆总管结石病例中出现。
EST是治疗胆总管结石相对安全有效的方法。最佳预后因素是单纯存在胆总管结石。胆总管结石合并胆囊结石预后较差,在这些病例中,应考虑在EST术后行胆囊切除术。